OverviewChartNewsTraderScreen

4imprint Group PLC/  GB0006640972  /

Cboe Europe BXE
2024-04-19  10:11:26 AM Chg. -100.00 Volume Bid10:14:00 AM Ask10:11:53 AM High Low
6,150.00GBX -1.60% 290
Turnover(GBP): 17,856		 6,030.00Bid Size: 18 6,170.00Ask Size: 29 6,245.00 6,100.00
Newsfile Corp 10:21 AM Digital Doc Fosters Unprecedented Revenue Growth Through Its AI-Backed Practice Growth Platform
TeleTrader 10:17 AM US down premarket, Dow loses 160 points
GlobeNewswire 10:07 AM Amarna Therapeutics announces appointment of Aurelia Caparrós as new Chief Business Officer
TeleTrader 10:05 AM Von der Leyen urges restraint in Middle East
GlobeNewswire 10:00 AM INVZ INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Innoviz Technologies Ltd. Inve...
GlobeNewswire 10:00 AM FOXF INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fox Factory Holding Corp. Inve...
GlobeNewswire 10:00 AM CC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that The Chemours Company Investors w...
TeleTrader 9:58 AM Medvedev: Zelensky should be afraid
GlobeNewswire 9:30 AM HSBC Continental Europe: Post Stabilisation Notice
TeleTrader 9:18 AM Iran: Israel has already seen our response
TeleTrader 9:01 AM Europe opens lower with Middle East in focus
GlobeNewswire 9:00 AM NEXEN Tire hosts ‘2024 Purple Summit Korea’
TeleTrader 8:41 AM Israel will allegedly not take responsibility for Iran strike
TeleTrader 8:29 AM IAEA confirms no damage to Iran's nuclear facilities
TeleTrader 8:26 AM US Israel embassy warns staff against travel
TeleTrader 8:03 AM UK retail sales up by 0.8% in March
TeleTrader 8:01 AM German producer prices down by 2.9% in March
TeleTrader 7:36 AM Europe down in premarket amid Middle East tensions
TeleTrader 7:19 AM Asia trades lower following Japan's CPI reading
GlobeNewswire 7:00 AM Sodexo announces solid H1 Fiscal 2024 results
GlobeNewswire 7:00 AM Pluxee delivers strong performance in the First Half and raises Fiscal 2024 Organic revenue growth a...
GlobeNewswire 7:00 AM Nykode Therapeutics Initiates Phase 2 Trial of VB10.16 in Second Line HPV16-Positive Cervical Cancer
GlobeNewswire 7:00 AM Addex to Present at the Swiss Biotech Day 2024
TeleTrader 6:56 AM US allegedly received advance notice of Israeli strike
TeleTrader 6:50 AM N. Korea, Belarus to start economic, cultural coop